measuregroup/AID178411

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103671488_AID178411_PMID2959776_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103677088_AID178411_PMID2959776_VALUE7 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103671546_AID178411_PMID2959776_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103676654_AID178411_PMID2959776_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103671488_AID178411_PMID2959776_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103671488_AID178411_PMID2959776_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103671565_AID178411_PMID2959776_VALUE5
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID955 http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Effective dose required for half maximal decrease of 5-HTP formation after subcutaneous administration of compound in hemispheres (cortex) for rat brain
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103671565 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103677088 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103671546 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103676654 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103671488
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID178411

Total number of triples: 18.